166
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 709-722 | Published online: 19 Mar 2022

References

  • de la Gala F, Piñeiro P, Reyes A, et al. Postoperative pulmonary complications, pulmonary and systemic inflammatory responses after lung resection surgery with prolonged one-lung ventilation. Randomized controlled trial comparing intravenous and inhalational anaesthesia. Br J Anaesth. 2017;119(4):655–663. doi:10.1093/bja/aex230
  • Stéphan F, Boucheseiche S, Hollande J, et al. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000;118(5):1263–1270. doi:10.1378/chest.118.5.1263
  • Efficace F, Cartoni C, Niscola P, et al. Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? Eur J Haematol. 2012;89(5):410–416. doi:10.1111/ejh.12004
  • Odor PM, Bampoe S, Gilhooly D, Creagh-Brown B, Moonesinghe SR. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ. 2020;368:m540. doi:10.1136/bmj.m540
  • Lakshminarasimhachar A, Smetana GW. Preoperative evaluation: estimation of pulmonary risk. Anesthesiol Clin. 2016;34(1):71–88. doi:10.1016/j.anclin.2015.10.007
  • Brunelli A, Drosos P, Dinesh P, Ismail H, Bassi V. The severity of complications is associated with postoperative costs after lung resection. Ann Thorac Surg. 2017;103(5):1641–1646. doi:10.1016/j.athoracsur.2016.10.061
  • McCannon J, Temel J. Comprehensive management of respiratory symptoms in patients with advanced lung cancer. J Support Oncol. 2012;10(1):1–9. doi:10.1016/j.suponc.2011.07.002
  • Cheville AL, Novotny PJ, Sloan JA, et al. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011;42(2):213–221. doi:10.1016/j.jpainsymman.2010.11.005
  • van Boekel RLM, Warlé MC, Nielen RGC, et al. Relationship between postoperative pain and overall 30-day complications in a broad surgical population: an observational study. Ann Surg. 2019;269(5):856–865. doi:10.1097/SLA.0000000000002583
  • van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–1449. doi:10.1093/annonc/mdm056
  • Chandler D, Mosieri C, Kallurkar A, et al. Perioperative strategies for the reduction of postoperative pulmonary complications. Best Pract Res Clin Anaesthesiol. 2020;34(2):153–166. doi:10.1016/j.bpa.2020.04.011
  • Janssen DJ, Wouters EF, Spruit MA. Psychosocial consequences of living with breathlessness due to advanced disease. Curr Opin Support Palliat Care. 2015;9(3):232–237. doi:10.1097/SPC.0000000000000146
  • Feinstein MB, Krebs P, Coups EJ, et al. Current dyspnea among long-term survivors of early-stage non-small cell lung cancer. J Thorac Oncol. 2010;5(8):1221–1226. doi:10.1097/JTO.0b013e3181df61c8
  • Sarna L, Cooley ME, Brown JK, Chernecky C, Elashoff D, Kotlerman J. Symptom severity 1 to 4 months after thoracotomy for lung cancer. Am J Crit Care. 2008;17(5):455–467; quiz 468. doi:10.4037/ajcc2008.17.5.455
  • Bauml J, Haas A, Simone CB, et al. Acupuncture for dyspnea in lung cancer: results of a feasibility trial. Integr Cancer Ther. 2016;15(3):326–332. doi:10.1177/1534735415624138
  • Ha D, Ries AL. Characterization of dyspnea in veteran lung cancer survivors following curative-intent therapy. J Cardiopulm Rehabil Prev. 2020;40(2):120–127. doi:10.1097/HCR.0000000000000464
  • Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg. 2015;150(3):613–619 e612. doi:10.1016/j.jtcvs.2015.05.057
  • Ban W, Lee JM, Ha JH, et al. Dyspnea as a prognostic factor in patients with non-small cell lung cancer. Yonsei Med J. 2016;57(5):1063. doi:10.3349/ymj.2016.57.5.1063
  • Obi ON, Judson MA, Birring SS, et al. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI). Respir Med. 2022;191:106436. doi:10.1016/j.rmed.2021.106436
  • Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST
  • Watkins ML, Wilcox TK, Tabberer M, et al. Shortness of breath with daily activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease. BMJ open. 2013;3(10):e003048. doi:10.1136/bmjopen-2013-003048
  • Reponen E, Korja M, Tuominen H. Simple preoperative patient-reported factors predict adverse outcome after elective cranial neurosurgery. Neurosurgery. 2018;83(2):197–202. doi:10.1093/neuros/nyx385
  • Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865–869. doi:10.1056/NEJMp0911494
  • Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi:10.1200/JCO.2015.63.0830
  • Mooney KH, Beck SL, Wong B, et al. Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT. Cancer Med. 2017;6(3):537–546. doi:10.1002/cam4.1002
  • Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med. 2014;8(2):151–161. doi:10.1586/17476348.2014.879530
  • Dai W, Xie S, Zhang R, et al. Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol. BMJ open. 2019;9(10):e030726. doi:10.1136/bmjopen-2019-030726
  • Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011;16(2):217–227. doi:10.1634/theoncologist.2010-0193
  • Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
  • Yang X, Zhan C, Li M, et al. Lobectomy versus sublobectomy in metachronous second primary lung cancer: a propensity score study. Ann Thorac Surg. 2018;106(3):880–887. doi:10.1016/j.athoracsur.2018.04.071
  • Dai W, Feng W, Zhang Y, et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol. 2022;JCO2101344. doi:10.1200/JCO.21.01344
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae
  • Agostini P, Cieslik H, Rathinam S, et al. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax. 2010;65(9):815–818. doi:10.1136/thx.2009.123083
  • Li S, Fan J, Liu J, et al. Neoadjuvant therapy and risk of bronchopleural fistula after lung cancer surgery: a systematic meta-analysis of 14 912 patients. Jpn J Clin Oncol. 2016;46(6):534–546. doi:10.1093/jjco/hyw037
  • Shinohara S, Kobayashi K, Kasahara C, et al. Long-term impact of complications after lung resections in non-small cell lung cancer. J Thorac Dis. 2019;11(5):2024–2033. doi:10.21037/jtd.2019.04.91
  • Mahajan AK, Doeing DC, Hogarth DK. Isolation of persistent air leaks and placement of intrabronchial valves. J Thorac Cardiovasc Surg. 2013;145(3):626–630. doi:10.1016/j.jtcvs.2012.12.003
  • Savardekar A, Gyurmey T, Agarwal R, et al. Incidence, risk factors, and outcome of postoperative pneumonia after microsurgical clipping of ruptured intracranial aneurysms. Surg Neurol Int. 2013;4:24. doi:10.4103/2152-7806.107894
  • Jammer I, Wickboldt N, Sander M, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88–105. doi:10.1097/EJA.0000000000000118
  • Jones BL. TRAJ: group-based modeling of longitudinal data; 2005. Available from: http://www.andrew.cmu.edu/user/bjones/. Accessed December 22, 2020.
  • Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013;22(9):2331–2339. doi:10.1007/s11136-013-0380-2
  • Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med. 2000;19(1):113–132. doi:10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O
  • Kim ES, Kim YT, Kang CH, et al. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1317–1326. doi:10.2147/COPD.S105206
  • Pezzuto A, Terzo F, Graziani ML, Ricci A, Bruno P, Mariotta S. Lung cancer requires multidisciplinary treatment to improve patient survival: a case report. Oncol Lett. 2017;14(3):3035–3038. doi:10.3892/ol.2017.6511
  • Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006;144(8):581–595. doi:10.7326/0003-4819-144-8-200604180-00009
  • Pezzuto A, Spoto C, Vincenzi B, Tonini G. Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level. J Comp Eff Res. 2013;2(3):335–343. doi:10.2217/cer.13.25
  • Gallart L, Canet J. Post-operative pulmonary complications: understanding definitions and risk assessment. Best Pract Res Clin Anaesthesiol. 2015;29(3):315–330. doi:10.1016/j.bpa.2015.10.004
  • Barisione G, Rovida S, Gazzaniga GM, Fontana L. Upper abdominal surgery: does a lung function test exist to predict early severe postoperative respiratory complications? Eur Respir J. 1997;10(6):1301–1308. doi:10.1183/09031936.97.10061301
  • Whisenant MS, Williams LA, Garcia Gonzalez A, et al. What do patients with non-small-cell lung cancer experience? Content domain for the MD Anderson Symptom Inventory for lung cancer. JCO Oncol Pract. 2020;16(10):e1151–e1160. doi:10.1200/JOP.19.00577
  • Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002;23(5):417–423. doi:10.1016/S0885-3924(02)00376-7
  • Shi Q, Lee JW, Wang XS, et al. Testing symptom severity thresholds and potential alerts for clinical intervention in patients with cancer undergoing chemotherapy. JCO Oncol Pract. 2020;16(9):e893–e901.
  • Selby D, Cascella A, Gardiner K, et al. A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manage. 2010;39(2):241–249. doi:10.1016/j.jpainsymman.2009.06.010
  • Chow E, Ding K, Parulekar WR, et al. Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life. Support Care Cancer. 2016;24(4):1617–1623. doi:10.1007/s00520-015-2957-5
  • Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277–284. doi:10.1016/0304-3959(94)00178-H
  • Wang XS, Zhao F, Fisch MJ, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–432. doi:10.1002/cncr.28434
  • Hu XL, Xu ST, Wang XC, et al. Development and validation of nomogram estimating post-surgery hospital stay of lung cancer patients: relevance for predictive, preventive, and personalized healthcare strategies. EPMA J. 2019;10(2):173–183. doi:10.1007/s13167-019-00168-z
  • Serpa Neto A, Hemmes SN, Barbas CS, et al. Incidence of mortality and morbidity related to postoperative lung injury in patients who have undergone abdominal or thoracic surgery: a systematic review and meta-analysis. Lancet Respir Med. 2014;2(12):1007–1015. doi:10.1016/S2213-2600(14)70228-0
  • Yun J, Lee J, Shin S, et al. Video-assisted thoracoscopic lobectomy versus open lobectomy in the treatment of large lung cancer: propensity-score matched analysis. J Cardiothorac Surg. 2022;17(1):2. doi:10.1186/s13019-021-01749-8
  • Sun D, Chen P, Liu L, et al. The 5-year survival rate of 11958 postoperative non-small cell lung cancer patients in stage I-IIIA by two different follow-up patterns: a multi-center, real-world study. Chin J Clin Thorac Cardiovasc Surg. 2021;28(6):615–622.
  • Hirschfeld G, Zernikow B. Variability of ”optimal” cut points for mild, moderate, and severe pain: neglected problems when comparing groups. Pain. 2013;154(1):154–159. doi:10.1016/j.pain.2012.10.008
  • Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CC. Cut points on 0–10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage. 2013;45(6):1083–1093. doi:10.1016/j.jpainsymman.2012.06.007